Mitigation of endometriosis using regenerative cerium oxide nanoparticles

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 9, Issue 3, 2013, Pages 439-448

  Chaudhury, Koel ^a   Babu K, Narendra ^a   Singh, Abhay K ^a   Das, Soumen ^b   Kumar, Amit ^b   Seal, Sudipta ^b  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

^b University of Central Florida   (United States)

Author keywords

Anti angiogenesis; Antioxidant; Cerium oxide nanoparticles; Endometriosis

Indexed keywords

ADVERSE EFFECT; ANGIOGENESIS; ANTI-ANGIOGENESIS; CERIUM OXIDE NANOPARTICLE; ENDOMETRIOSIS; SCAVENGING PROPERTIES; SCIENTIFIC COMMUNITY; SUPEROXIDE RADICAL;

ANTIOXIDANTS; FREE RADICALS; NANOPARTICLES; OXYGEN;

OXIDES;

CERIUM OXIDE; METAL NANOPARTICLE; NANOCERIA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; MOUSE; NONHUMAN; OOCYTE; OXIDATIVE STRESS; PREGNANCY;

ANIMALS; ANTIGENS, CD34; ANTIOXIDANTS; BIOLOGICAL MARKERS; CELL LINE; CERIUM; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMANS; LIPID PEROXIDES; MICE; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; NEOVASCULARIZATION, PATHOLOGIC; OOCYTES; OXIDATION-REDUCTION; OXIDATIVE STRESS; PARTICLE SIZE; REACTIVE OXYGEN SPECIES;

MURINAE; MUS;

EID: 84875482830     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2012.08.001     Document Type: Article

References (42)

1. McLeod B.S., Retzloff M.G. Epidemiology of endometriosis: an assessment of risk factors. Clin Obstet Gynecol 2010, 53:389-396.
2. Colette S.B., Donnez J. Are aromatase inhibitors effective in endometriosis treatment?. Expert Opin Investig Drugs 2011, 20:917-931.
3. Martin D.C. Hysterectomy for treatment of pain associated with endometriosis. J Minim Invasive Gynecol 2006, 13:566-572.
4. Augoulea A., Mastorakos G., Lambrinoudaki I., Christodoulakos G., Creatsas G. The role of the oxidative-stress in the endometriosis-related infertility. Gynecol Endocrinol 2009, 25:75-81.
5. Szczepańska M., Koźlik J., Skrzypczak J., Mikołajczyk M. Oxidative stress may be a piece in the endometriosis puzzle. Fertil Steril 2003, 79:1288-1293.
6. Jackson L.W., Schisterman E.F., Dey-Rao R., Browne R., Armstrong D. Oxidative stress and endometriosis. Hum Reprod 2005, 20:2014-2020.
7. Mier-Cabrera J., Aburto-Soto T., Burrola-Méndez S., Jiménez-Zamudio L., Tolentino M., Casanueva E., et al. Women with endometriosis improved their peripheral antioxidant markers after the application of a high antioxidant diet. Reprod Biol Endocrinol 2009, 28:54.
8. Melo A.S., Rosa-e-Silva JCs, Rosa-e-Silva ACJdS, Poli-Neto O.B., Ferriani R.A., Vieira C.S. Unfavorable lipid profile in women with endometriosis. Fertil Steril 2010, 93:2433-2436.
9. Healy D.L., Rogers P.A.W., Hii L., Wingfield M. Angiogenesis: a new theory for endometriosis. Hum Reprod Update 1998, 4:736-740.
10. Taylor R.N., Jie Y., Torres P.B., Schickedanz A.C., Park J.K., Mueller M.D., et al. Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci 2009, 16:140-146.
11. McLaren J., Prentice A., Charnock-Jones D.S., Smith S.K. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 1996, 11:220-223.
12. Ferrero S., Ragni N., Remorgida V. Antiangiogenic therapies in endometriosis. Br J Pharmacol 2006, 149:133-135.
13. Taylor H.S., Osteen K.G., Bruner-Tran K.L., Krikun G., Sokalska A., Duleba A.J. Novel therapies targeting endometriosis. Reprod Sci 2011, 18:814-823.
14. Celardo I., Traversa E., Ghibelli L. Cerium oxide nanoparticles: a promise for applications in therapy. J Exp Ther Oncol 2011, 9:47-51.
15. Hirst S.M., Karakoti A.S., Tyler R.D., Sriranganathan N., Seal S., Reilly C.M. Anti-inflammatory properties of cerium oxide nanoparticles. Small 2009, 5:2848-2856.
16. Karakoti A., Monteiro-Riviere N., Aggarwal R., Davis J., Narayan R., Self W., et al. Nanoceria as antioxidant: synthesis and biomedical applications. JOM J Minerals, Metals Mater Soc 2008, 60:33-37.
17. Kong L., Cai X., Zhou X., Wong L.L., Karakoti A.S., Seal S., et al. Nanoceria extend photoreceptor cell lifespan in tubby mice by modulation of apoptosis/survival signaling pathways. Neurobiol Dis 2011, 42:514-523.
18. Estevez A.Y., Pritchard S., Harper K., Aston J.W., Lynch A., Lucky J.J., et al. Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia. Free Radic Biol Med 2011, 51:1155-1163.
19. Colon J., Hsieh N., Ferguson A., Kupelian P., Seal S., Jenkins D.W., et al. Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine: Nanotechnol, Biol Med 2010, 6:698-705.
20. Anderson R.E., LaVail M.M., Hollyfield J.G., Chen J., Patil S., Seal S., et al. Nanoceria particles prevent ROI-induced blindness. Recent advances in retinal degeneration 2008, 53-59. Springer, New York.
21. Zhou X., Wong L.L., Karakoti A.S., Seal S., McGinnis J.F. Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the knockout mouse. PLoS One 2011, 6:e16733.
22. Niu J., Azfer A., Rogers L.M., Wang X., Kolattukudy P.E. Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc Res 2007, 73:549-559.
23. Das M., Patil S., Bhargava N., Kang J.-F., Riedel L.M., Seal S., et al. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 2007, 28:1918-1925.
24. Karakoti A.S., Singh S., Kumar A., Malinska M., Kuchibhatla S.V.N.T., Wozniak K., et al. PEGylated nanoceria as radical scavenger with tunable redox chemistry. J Am Chem Soc 2009, 131:14144-14145.
25. Nowak N.M., Fischer O.M., Gust T.C., Fuhrmann U., Habenicht U.F., Schmidt A. Intraperitoneal inflammation decreases endometriosis in a mouse model. Hum Reprod 2008, 23:2466-2474.
26. Marian A.J., Senthil V., Chen S.N., Lombardi R. Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation. J Am Coll Cardiol 2006, 47(4):827-834.
27. Buege J., Aust S. Microsomal lipid peroxidation. Methods Enzymol 1978, 52:2-10.
28. Chapple I., Mason G., Garner I., Matthews J., Thorpe G., SM S.R., et al. Enhanced chemiluminescent assay for measuring the total antioxidant capacity of serum, saliva and crevicular fluid. Ann Clin Biochem 1997, 34:412-421.
29. Ganesh A., Chattopadhyay R., Narendra Babu K., Chakravarty B., Chaudhury K. Analysis of spindle characteristics and embryo quality in mice stimulated with letrozole using Polscope imaging. Fertil Steril 2010, 93:1477-1481.
30. Textbook of therapeutics: drug and disease management Philadelphia 2006, Lippincott Williams & Wilkins. R.A. Helms, D.J. Quan (Eds.).
31. Blumenfeld Z. Hormonal suppressive therapy for endometriosis may not improve patient health. Fertil Steril 2004, 81:487-492.
32. Greer J.B., Modugno F., Allen G.O., Ness R.B. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer. Obstet Gynecol 2005, 105:731-740.
33. Guo S.-W. Recurrence of endometriosis and its control. Hum Reprod Update 2009, 15:441-461.
34. Srinivas A., Rao P.J., Selvam G., Murthy P.B., Reddy P.N. Acute inhalation toxicity of cerium oxide nanoparticles in rats. Toxicol Lett 2011, 205:105-115.
35. Wingard C., Walters D., Cathey B., Hilderbrand S., Katwa P., Lin S., et al. Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation. Nanotoxicology 2010, 5:531-545.
36. Hirst S.M., Karakoti A., Singh S., Self W., Tyler R., Seal S., et al. Bio-distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice. Environ Toxicol 2011.
37. Wang W.H., Meng L., Hackett R.J., Keefe D.L. Developmental ability of human oocytes with or without birefringent spindles imaged by Polscope before insemination. Hum Reprod 2001, 16:1464-1468.
38. Moon J.H., Hyun C.S., Lee S.W., Son W.Y., Yoon S.H., Lim J.H. Visualization of the metaphase II meiotic spindle in living human oocytes using the Polscope enables the prediction of embryonic developmental competence after ICSI. Hum Reprod 2003, 18:817-820.
39. Rienzi L., Martinez F., Ubaldi F., Minasi M.G., Iacobelli M., Tesarik J., et al. Polscope analysis of meiotic spindle changes in living metaphase II human oocytes during the freezing and thawing procedures. Hum Reprod 2004, 19:655-659.
40. Wang W.-H., Meng L., Hackett R.J., Odenbourg R., Keefe D.L. The spindle observation and its relationship with fertilization after intracytoplasmic sperm injection in living human oocytes. Fertil Steril 2001, 75:348-353.
41. Fang C., Tang M., Li T., Peng W.-L., Zhou C.-Q., Zhuang G.-L., et al. Visualization of meiotic spindle and subsequent embryonic development in in vitro and in vivo matured human oocytes. J Assist Reprod Genet 2007, 24:547-551.
42. D'Hooghe T.M., Kyama C.M., Chai D., Fassbender A., Vodolazkaia A., Bokor A., et al. Nonhuman primate models for translational research in endometriosis. Reprod Sci 2009, 16:152-161.